/PRNewswire/ According to Coherent Market Insights, the global bone marrow transplant market is estimated to be valued at US$ 10,356.1 million in 2022 and.
Versant Ventures Launches Cimeio Therapeutics with $50 Million Series A - read this article along with other careers information, tips and advice on BioSpace
The Food and Drug Administration on December 15 approved the first-ever drug to be used for the prevention of acute graft versus host disease (aGVHD) in adult and pediatric patients, opening the door for safer bone marrow and blood stem cell transplants in patients who do not have a perfectly matched graft donor.